1. NuVasive received an average “buy” recommendation from 14 ratings firms, and four equities research analysts rating the stock with a “hold” and nine with a “buy.” The average 12-month target price is $44.75, according to an InterCooler report.
2. LDR’s CFO Robert McNamara sold 5,555 shares of company stock on Dec. 11 at an average price of $32 per share for a total transaction value of $177,760. He now owns 346 shares valued at $11,072, according to a Watch List News report.
3. K2M hit a 52-week high on Dec. 12 when the stock price peaked at $20.55. The stock opened at $19.85 and closed at $19.86 on Dec. 12. The company’s 52-week high came on a volume of 130,857, according to an Equities report.
4. Medtronic received an average “buy” rating from 20 analysts covering the stock, with three rating a “hold” and 14 giving a “buy” rating. The company’s average 12-month target price is $75.25, according to a report from The Legacy.
5. Smith & Nephew has “hold” consensus rating from ratings firms, with 10 giving “hold” recommendations and seven giving the company’s stock a “buy rating. The average 12-month price target is $97, according to a Sleek Money report.
6. Stryker Director Ronda Stryker sold 21,000 shares of the company’s stock on the open market on Dec. 11 at an average price of $93.50 for a total transaction value of $1.9 million. Ms. Stryker now directly owns 174,605, valued at $16.3 million, according to a Dakota Financial News report.
More articles on orthopedic devices:
K2M plans new $28M headquarters—5 things to know
Cervical disc replacement distribution agreement—SDRI signs with joimax: 5 things to know
Who will win China? Medical device companies seize opportunity
